Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency-related cirrhosis

Liver Transplantation

Volumn 19, Issue 12, 2013, Pages 1370-1376

  Carey, Elizabeth J ^a   Iyer, Vivek N ^b   Nelson, Darlene R ^b   Nguyen, Justin H ^c   Krowka, Michael J ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN;

ACUTE GRAFT REJECTION; ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CANCER RADIOTHERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GRAFT RECIPIENT; HUMAN; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PHENOTYPE; PLEURA EFFUSION; PRIORITY JOURNAL; RADIATION PNEUMONIA; RETROSPECTIVE STUDY; SURVIVAL RATE;

ALPHA 1-ANTITRYPSIN DEFICIENCY; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUNG; MALE; MIDDLE AGED; PHENOTYPE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84889099843     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23744     Document Type: Article

References (12)

1. de Serres FJ, Blanco I, Fernández-Bustillo E,. PI S and PI Z alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data. Monaldi Arch Chest Dis 2007; 67: 184-208.
2. Stoller JK, Aboussouan LS,. Alpha1-antitrypsin deficiency. Lancet 2005; 365: 2225-2236.
3. Clark V, Brantly M, Dhanasekaran R, Schreck P, Rouhani F, Nelson D,. ALT abnormalities in adults with alpha-1 antitrypsin deficiency [abstract]. J Hepatol 2011; 54 (suppl 1): S354.
4. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168: 818-900.
5. Graziadei IW, Joseph JJ, Wiesner RH, Therneau TM, Batts KP, Porayko MK,. Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency. Hepatology 1998; 28: 1058-1063.
6. Kemmer N, Kaiser T, Zacharias V, Neff GW,. Alpha-1-antitrypsin deficiency: outcomes after liver transplantation. Transplant Proc 2008; 40: 1492-1494.
7. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al.; for ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J 2005; 26: 153-161.
8. Dawwas MF, Davies SE, Griffiths WJ, Lomas DA, Alexander GJ,. Prevalence and risk factors for liver involvement in individuals with PiZZ-related lung disease. Am J Respir Crit Care Med 2013; 187: 502-508.
9. Jain AB, Patil V, Sheikh B, Apostolakos M, Ryan C, Kashyap R, Orloff M,. Effect of liver transplant on pulmonary functions in adult patients with alpha 1 antitrypsin deficiency: 7 cases. Exp Clin Transplant 2010; 8: 4-8.
10. Vennarecci G, Gunson BK, Ismail T, Hübscher SG, Kelly DA, McMaster P, Elias E,. Transplantation for end stage liver disease related to alpha 1 antitrypsin. Transplantation 1996; 61: 1488-1495.
11. Wise RA,. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression. Am J Med 2006; 119 (suppl 1): 4-11.
12. Strange C, Stoller JK, Sandhaus RA, Dickson R, Turino G,. Results of a survey of patients with alpha-1 antitrypsin deficiency. Respiration 2006; 73: 185-190.